Table 1 Response assessment during the remission induction therapy
Days after the start of administration | -1 | 14 | 28 | 42 | 56 |
|---|---|---|---|---|---|
Nuclear cell count (× 104/μL) | 6.0 | 7.0 | 10.0 | 12.0 | 4.0 |
Blast+Promyelocyte (%) | 5.8 | 17.8 | 0.8 | 1.2 | 0.6 |
Myeloid (%) | 51.2 | 32.6 | 29.4 | 21.6 | 34.2 |
Erythroid (%) | 22.6 | 28.8 | 55.0 | 70.0 | 33.2 |
Others (%) | 20.4 | 20.8 | 14.8 | 7.2 | 32.0 |
PML-RARα FISH (%) | 5.0 | 83.0 | 33.0 | 9.0 | 0.0 |
CD11b (%) | 5.0 | 27.0 | 43.2 | 59.3 | ND |
CD15 (%) | 8.6 | 23.2 | 38.5 | 47.2 | ND |
CD117 (%) | 94.5 | 30.4 | 41.3 | 23.9 | ND |
CD34 (%) | 38.0 | 14.4 | 26.2 | 15.8 | ND |